2019 annual financial data
Rigel Pharmaceuticals 2019 Operating margin
Rigel Pharmaceuticals 2019 operating margin with verified reported values.
Direct answer
Operating margin was -116.53%.
Operating income was -69,091,000 USD and net income was -66,546,000 USD.
Operating cash flow was -41,510,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 59,288,000 USD
- Operating income
- -69,091,000 USD
- Net income
- -66,546,000 USD
- Operating cash flow
- -41,510,000 USD